Politics

358 readers

296 users here now

For civil discussion of US politics. Be excellent to each other.

Rule 1: Posts have the following requirements:
▪️ Post articles about the US only

▪️ Title must match the article headline

▪️ Recent (Past 30 Days)

▪️ No Screenshots/links to other social media sites or link shorteners

Rule 2: Do not copy the entire article into your post. One or two small paragraphs are okay.

Rule 3: Articles based on opinion (unless clearly marked and from a serious publication-No Fox News or equal), misinformation or propaganda will be removed.

Rule 4: Posts or comments that are homophobic, transphobic, racist, sexist, ableist, will be removed.

Rule 5: Keep it civil. It’s OK to say the subject of an article is behaving like a jerk. It’s not acceptable to say another user is a jerk. Cussing is fine.

Rule 6: Memes, spam, other low effort posting, reposts, advocating violence, off-topic, trolling, offensive, regarding the moderators or meta in content may be removed at any time.

USAfacts.org

The Alt-Right Playbook

Media owners, CEOs and/or board members

founded 2 years ago

MODERATORS

[email protected]

Medicare announces lower prices on 10 common, high-cost drugs (www.nbcnews.com)

submitted 4 months ago by [email protected] to c/[email protected]

0 comments fedilink hide all child comments

Eliquis, a blood thinner from Bristol Myers Squibb and Pfizer: $231 negotiated price, down from $521 list price.
Xarelto, a blood thinner from Johnson & Johnson; $197 negotiated price, down from $517 list price.
Januvia, a diabetes drug from Merck: $113 negotiated price, down from $527 list price.
Jardiance, a diabetes drug from Boehringer Ingelheim and Eli Lilly: $197 negotiated price, down from $573 list price.
Enbrel, a rheumatoid arthritis drug from Amgen: $2,355 negotiated price, down from $7,106 list price.
Imbruvica, a drug for blood cancers from AbbVie and Johnson & Johnson: $9,319 negotiated price, down from $14,934 list price.
Farxiga, a drug for diabetes, heart failure and chronic kidney disease from AstraZeneca: $178 negotiated price, down from $556 list price.
Entresto, a heart failure drug from Novartis: $295 negotiated price, down from $628 list price.
Stelara, a drug for psoriasis and Crohn’s disease from J&J: $4,695 negotiated price, down from $13,836 list price.
Fiasp and NovoLog, diabetes drugs from Novo Nordisk: $119 negotiated price, down from $495 list price.

The new negotiated prices were compared to the 2023 list prices of the drugs.

no comments (yet)

sorted by: hot top controversial new old

there doesn't seem to be anything here